We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current MRUS market cap is 3.59B. The company's latest EPS is USD and P/E is N/A.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 7.89M | 7.33M | 11.77M | 9.14M | 26.49M |
| Operating Income | -46.81M | -69.17M | -72.23M | -88.65M | -75.74M |
| Net Income | -34.46M | -50.04M | -99.91M | -30.92M | -98.24M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 29.94M | 49.11M | 41.59M | 43.95M | 36.13M |
| Operating Income | -75.88M | -89.98M | -160.04M | -156.55M | -272.07M |
| Net Income | -85.51M | -66.82M | -131.19M | -154.94M | -215.33M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 498.08M | 892.23M | 844.68M | 782.69M | 730.92M |
| Total Liabilities | 148.64M | 145.46M | 141.42M | 134.77M | 134.8M |
| Total Equity | 349.45M | 746.77M | 703.26M | 647.93M | 596.12M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 231.22M | 456.6M | 376.54M | 455.49M | 782.69M |
| Total Liabilities | 128.95M | 140.4M | 129.49M | 99.15M | 134.77M |
| Total Equity | 102.26M | 316.2M | 247.06M | 356.34M | 647.93M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -44.39M | -38.76M | -119.18M | -185.84M | -96.46M |
| Investing | -12.08M | -8.85M | -142.52M | -220.22M | -8.72M |
| Financing | 30.16M | 475.05M | 485.94M | 494.01M | 6.74M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -79.9M | -59.63M | -149.9M | -142.21M | -185.84M |
| Investing | -1.49M | -146.62M | 2.8M | -27.02M | -220.22M |
| Financing | 39.52M | 281.96M | 58.74M | 230.09M | 494.01M |
| Market Cap | 3.59B |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 69.21M |
| Average Volume (1 week) | 437.45k |
| Average Volume (1 Month) | 747.58k |
| 52 Week Change | -4.03% |
| 52 Week High | 62.98 |
| 52 Week Low | 33.19 |
| Spread (Intraday) | 0.11 (0.21%) |
| Company Name | Merus NV |
| Address |
uppsalalaan 17 utrecht, utrecht 3584 CT |
| Website | https://www.merus.nl |
| Industry | gen med & surgical hospitals (8062) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
